Wedbush Securities’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39K Hold
40,850
﹤0.01% 1144
2025
Q1
$19K Hold
40,850
﹤0.01% 1105
2024
Q4
$30K Hold
40,850
﹤0.01% 1125
2024
Q3
$64K Hold
40,850
﹤0.01% 1072
2024
Q2
$69K Sell
40,850
-800
-2% -$1.35K ﹤0.01% 1162
2024
Q1
$100K Buy
+41,650
New +$100K ﹤0.01% 1180
2020
Q4
Sell
-320,509
Closed -$462K 931
2020
Q3
$462K Sell
320,509
-66,526
-17% -$95.9K 0.04% 450
2020
Q2
$772K Buy
387,035
+32,750
+9% +$65.3K 0.07% 280
2020
Q1
$691K Sell
354,285
-13,377
-4% -$26.1K 0.08% 273
2019
Q4
$1.53M Sell
367,662
-31,022
-8% -$129K 0.14% 171
2019
Q3
$1.2M Buy
398,684
+204,345
+105% +$615K 0.12% 202
2019
Q2
$1.22M Buy
194,339
+48,182
+33% +$303K 0.12% 192
2019
Q1
$813K Sell
146,157
-28,285
-16% -$157K 0.09% 263
2018
Q4
$1.16M Buy
174,442
+49,312
+39% +$327K 0.15% 167
2018
Q3
$1.34M Sell
125,130
-26,220
-17% -$280K 0.15% 148
2018
Q2
$1.82M Sell
151,350
-4,046
-3% -$48.5K 0.23% 93
2018
Q1
$1.33M Buy
155,396
+16,290
+12% +$140K 0.17% 132
2017
Q4
$1.37M Buy
139,106
+26,873
+24% +$265K 0.17% 135
2017
Q3
$1.38M Buy
112,233
+24,593
+28% +$302K 0.18% 120
2017
Q2
$1.44M Buy
87,640
+34,586
+65% +$569K 0.19% 113
2017
Q1
$761K Buy
53,054
+33,140
+166% +$475K 0.1% 239
2016
Q4
$275K Buy
+19,914
New +$275K 0.04% 538
2015
Q2
Sell
-5,457
Closed -$36K 751
2015
Q1
$36K Buy
+5,457
New +$36K 0.01% 707
2014
Q4
Sell
-1,429
Closed -$14K 738
2014
Q3
$14K Hold
1,429
﹤0.01% 683
2014
Q2
$16K Hold
1,429
﹤0.01% 654
2014
Q1
$17K Hold
1,429
﹤0.01% 619
2013
Q4
$18K Hold
1,429
﹤0.01% 580
2013
Q3
$24K Hold
1,429
0.01% 570
2013
Q2
$22K Buy
+1,429
New +$22K 0.01% 546